SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Novartis AG Suspends Commissioning Of New $150 Million Plant
October 15, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
Novartis AG’s Secukinumab Has Consistent Activity In Psoriasis
October 13, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Oxford BioMedica PLC Inks Transformational $90 Million Deal With Novartis AG
October 10, 2014
 · 
2 min read
Price Tag May Be The Challenge For Novartis AG And Juno Therapeutics’ Magical Cancer Drugs
October 8, 2014
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Three Executives To Leave Novartis AG After GlaxoSmithKline, Eli Lilly and Company Deals
October 8, 2014
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Novartis AG Ditches Hepatitis C Drug Dreams, Breaks $440 Million Enanta Pharmaceuticals, Inc. Deal
October 1, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Drug Development
Novartis AG To Roll Out 15 Abstracts At EADV
October 1, 2014
 · 
1 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Beach
Analyst: Novartis AG, Celgene Might Go Toe-to-Toe Over Psoriasis Drugs
September 26, 2014
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG Reports Two Positive Phase 3 Trials For Arthritis Drug
September 25, 2014
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Novartis Pharmaceuticals Corporation Therapy Gilenya(TM) Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease Severity, New Analysis Shows
April 11, 2011
 · 
10 min read
Policy
Novartis AG Aims to Resurrect ‘Zombie’ Drug After Four Years
April 6, 2011
 · 
1 min read
Pharm Country
Novartis AG’s Gilenya to Cost EU24,000 a Year in Germany
April 6, 2011
 · 
1 min read
Deals
Novartis AG Buys 85 Percent Stake In Chinese Vaccines Company, Zhejiang Tianyuan
March 22, 2011
 · 
1 min read
Drug Development
Novartis AG, Roche’s Xolair Helps Kids With Severe Milk Allergies
March 22, 2011
 · 
1 min read
Job Trends
Novartis AG Aims to Recover Pace in China; Creates Jobs
March 21, 2011
 · 
1 min read
FDA
Novartis AG Receives EU Approval for Gilenya
March 21, 2011
 · 
1 min read
Job Trends
Swiss Drugs Giant Novartis AG Reveals UK Jobs Cuts Plan
March 17, 2011
 · 
1 min read
Drug Development
Novartis AG, Roche’s Xolair Blunts Asthma Attacks in Children in U.S. Cities
March 17, 2011
 · 
1 min read
Drug Development
Novartis AG’s Onbrez Plus Rival, Pfizer Inc.'s Drug Boosts Lung Function
February 10, 2011
 · 
1 min read
Load More